Upgrade to SI Premium - Free Trial

Form 3 AVIENT CORP For: Jun 01 Filed by: Di Salvo Giuseppe

June 1, 2026 4:52 PM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Di Salvo Giuseppe
(Last) (First) (Middle)
AVIENT CORPORATION
33587 WALKER ROAD
(Street)
AVON LAKE OH 44012
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/01/2026 		3. Issuer Name and Ticker or Trading Symbol
AVIENT CORP [ AVNT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Chief Financial Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 18,300.401
I
Supplemental Plan (1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (2) (2) Common Stock 1,761 (3) D
Restricted Stock Units (4) (4) Common Stock 1,179 (3) D
Restricted Stock Units (5) (5) Common Stock 2,783 (3) D
Stock Appreciation Rights (6) 02/11/2029 Common Stock 1,637 31.54 D
Stock Appreciation Rights (7) 02/10/2030 Common Stock 3,713 31.48 D
Stock Appreciation Rights (8) 02/08/2031 Common Stock 5,470 42.27 D
Stock Appreciation Rights (9) 02/14/2032 Common Stock 4,250 52.64 D
Stock Appreciation Rights (10) 02/17/2033 Common Stock 5,000 42.93 D
Stock Appreciation Rights (11) 02/22/2034 Common Stock 5,250 39.27 D
Explanation of Responses:
1. The information in this report is based on a plan statement as of June 1, 2026.
2. The restricted stock units vest 3 years from the date of grant on February 22, 2027.
3. Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
4. The restricted stock units vest in substantially equal installments on each of February 19, 2027 and February 19, 2028, unless earlier vested or terminated pursuant to the terms of the grant agreement.
5. The restricted stock units vest in substantially equal installments on each of February 20, 2027, February 20, 2028 and February 20, 2029, unless earlier vested or terminated pursuant to the terms of the grant agreement.
6. Stock appreciation rights ("SARs") become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.
7. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.
8. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years
9. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.
10. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $42.93 per share and no more than one-third of the grant can vest per year during the first three years.
11. SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of twenty consecutive trading days) from the grant date closing price of $39.27 per share and no more than one-third of the grant can vest per year during the first three years.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Robert K. James, Power of Attorney for Giuseppe Di Salvo 06/01/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

ATTACHMENTS / EXHIBITS

POWER OF ATTORNEY (PUBLIC): DI SALVO POA

Categories

SEC Filings